Atlas Trials

Safety, Efficacy and Pharmacokinetics of ALD403

Clinical trial NCT01772524 · COMPLETED

Trial details

NCT number
NCT01772524
Sponsor
Alder Biopharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Migraine
Start date
2013-01-01
Primary completion
2013-12-01
Enrollment
163

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.